TAPCA Action Items

wrench

This page will progressively set out TAPCA’s principal action items as they become more clearly defined, refined, and operationally feasible.

Action Item 1:
PDAC Exceptionalism

With regard to our priorities of reducing excessive regulatory burden in pancreatic cancer research, accelerating data flow, and advancing PDAC Exceptionalism, please find below a proposed six-step action plan set out in the attached PDF document.

 

Action Item 2:
Creating the World’s Largest Patients’ Registry in PDAC.

With increasing stratification and a growing array of targeted therapies and interventions, matching the right PDAC treatment to the right Patient has become an increasingly complex task — the central challenge of personalised medicine.

Linking Patient information to available treatments, trials and other research programs remains a persistent challenge in the pancreatic cancer field.

A further central consideration is that occult micrometastatic disease is typically already present by the time PDAC becomes detectable with current technology. This means stage-shift through earlier detection may be the single largest lever available today — perhaps larger than anything realistically achievable on the treatment side alone in the near term.

It follows that building a vast network of registered PDAC Patients under TAPCA’s umbrella is fundamental: first, to significantly accelerate our clinical trials and research programs, and second to advance the pivotal field of early detection research — both essential to delivering the better outcomes Patients urgently need.

TAPCA investigators will therefore work to build the world’s largest PDAC Patient registry, in full compliance with privacy and data-sharing regulations, envisioning it as a turning point in the fight against pancreatic cancer — achieved in cooperation with Patient advocacy groups, general practitioners, and Patients and their families.

Action item: A key preliminary step in implementing such an initiative would be the convening of a dedicated multidisciplinary forum of TAPCA experts with experience in the legal, ethical, and regulatory barriers surrounding the collection, governance, and cross-institutional use of patient data and medical records. To organise this discussion forum, please contact TAPCA founder and coordinator, Dott. Paolo Rossi Barnard